So if another researcher decided to pursue clinical trials of this same drug, they would have no idea about the dangers identified from the previous trial and would put more people at risk of the same adverse health effects that had already been identified so generally do you agree that it would be a good public health measure to ensure that results of all registered trials, regardless if the drug is approved or not, are posted on the database?
Markey emphasizes the need for transparency in clinical trial results to protect public health.
Share & report
More from Ed Markey
You know, the Senator from Rhode Island is wise and precise in his analysis of the agenda of these companies. The Senator from Rhode Island and I have for 12 years led the effort, along with the Senator from Connecticut, to have offshore…
Mr. President, I am here to speak in opposition to the confirmation of Senator Kelly Loeffler to serve as Administrator of the Small Business Administration. I am concerned for the more than 722,000 small businesses that call Massachusetts…
Mr. President, on that, I ask for the yeas and nays. The PRESIDING OFFICER. Is there a sufficient second? There appears to be a sufficient second. The clerk will call the roll. The senior assistant legislative clerk called the roll.
Mr. President, I call up my amendment No. 911 and ask that it be reported by number. The PRESIDING OFFICER. The clerk will report. The senior assistant bill clerk read as follows: The Senator from Massachusetts [Mr. Markey] proposes an…
Other voices in this conversation
